Risk-adapted therapy for patients with untreated age-adjusted International Prognostic Index II or III diffuse large B cell lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 10 Aug 2016 Biomarkers information updated
- 23 Sep 2005 New trial record.